Thermo Fisher Scientific, AbbVie, Danaher, Moderna, and Fabrinet are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that use biological processes—like genetic engineering, drug research, and cell therapies—to develop medical and agricultural products. These stocks tend to be more volatile than those in established industries because their values hinge on lengthy research and development cycles, clinical trial results, and regulatory approvals. Investors are often attracted by the potential for breakthrough innovations but must also weigh the high scientific and commercialization risks. These companies had the highest dollar trading volume of any Biotech stocks within the last several days.
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of TMO traded up $4.34 during trading hours on Wednesday, hitting $425.81. The company had a trading volume of 1,044,877 shares, compared to its average volume of 1,961,046. The company's fifty day moving average price is $409.16 and its two-hundred day moving average price is $481.67. The company has a current ratio of 1.77, a quick ratio of 1.38 and a debt-to-equity ratio of 0.64. Thermo Fisher Scientific has a one year low of $385.46 and a one year high of $627.88. The company has a market capitalization of $160.74 billion, a PE ratio of 25.00, a price-to-earnings-growth ratio of 2.16 and a beta of 0.77.
Read Our Latest Research Report on TMO
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
ABBV stock traded up $1.53 on Wednesday, hitting $191.52. 1,328,230 shares of the company's stock were exchanged, compared to its average volume of 6,234,342. The firm has a 50 day moving average price of $186.85 and a two-hundred day moving average price of $188.22. The company has a debt-to-equity ratio of 44.14, a quick ratio of 0.64 and a current ratio of 0.76. AbbVie has a 12-month low of $163.52 and a 12-month high of $218.66. The stock has a market cap of $338.30 billion, a P/E ratio of 81.46, a price-to-earnings-growth ratio of 1.23 and a beta of 0.48.
Read Our Latest Research Report on ABBV
Danaher (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Danaher stock traded up $0.34 during trading hours on Wednesday, hitting $201.44. 1,233,490 shares of the stock traded hands, compared to its average volume of 3,501,095. The firm's 50 day moving average price is $195.27 and its 200-day moving average price is $207.84. The stock has a market capitalization of $144.16 billion, a price-to-earnings ratio of 39.16, a P/E/G ratio of 2.77 and a beta of 0.77. Danaher has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05.
Read Our Latest Research Report on DHR
Moderna (MRNA)
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.
Shares of NASDAQ MRNA traded up $1.42 during trading on Wednesday, reaching $30.11. 6,961,754 shares of the company traded hands, compared to its average volume of 8,622,678. Moderna has a 12-month low of $23.15 and a 12-month high of $129.39. The stock has a market cap of $11.64 billion, a P/E ratio of -3.44 and a beta of 1.85. The firm's fifty day simple moving average is $26.52 and its 200 day simple moving average is $31.61.
Read Our Latest Research Report on MRNA
Fabrinet (FN)
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.
FN stock traded up $0.27 during midday trading on Wednesday, hitting $289.38. 514,795 shares of the stock traded hands, compared to its average volume of 641,717. Fabrinet has a 1-year low of $148.55 and a 1-year high of $300.29. The stock's fifty day simple moving average is $236.68 and its 200-day simple moving average is $221.29. The firm has a market cap of $10.37 billion, a P/E ratio of 32.23 and a beta of 1.04.
Read Our Latest Research Report on FN
Featured Articles
Before you consider Thermo Fisher Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.
While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
